Glipizide 2.5 mg Extended-release tablets, 30-count bottle, Rx Only, Manufacture Supply Disruption — Actavis Inc (Moderate Risk —
Glipizide 2.5 mg Extended-release tablets, 30-count bottle, Rx Only, Manufacture Supply Disruption — Actavis Inc (Moderate Risk — is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: Glipizide 2.5 mg Extended-release tablets, 30-count bottle, Rx Only, Manufacture; Manufacturer: Actavi
| Drug name | Glipizide 2.5 mg Extended-release tablets, 30-count bottle, Rx Only, Manufacture |
|---|---|
| Manufacturer | Actavis Inc |
| Recall/Disruption reason | Failed Dissolution Specifications: Glipizide 2.5 mg ER Tablets exceeded dissolution specification rates for the 10 hour |
| Risk classification | Moderate Risk — Temporary Health Consequence |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-1457-2016 |
| Initiation date | 20160630 |
| Quantity affected | 167,152 bottles |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →